GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » Net Margin %

Sinphar Pharmaceutical Co (TPE:1734) Net Margin % : 6.35% (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sinphar Pharmaceutical Co's Net Income for the three months ended in Sep. 2024 was NT$48 Mil. Sinphar Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was NT$750 Mil. Therefore, Sinphar Pharmaceutical Co's net margin for the quarter that ended in Sep. 2024 was 6.35%.

The historical rank and industry rank for Sinphar Pharmaceutical Co's Net Margin % or its related term are showing as below:

TPE:1734' s Net Margin % Range Over the Past 10 Years
Min: -1.57   Med: 0.71   Max: 12.66
Current: 10.93


TPE:1734's Net Margin % is ranked better than
83.81% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs TPE:1734: 10.93

Sinphar Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Sinphar Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co Net Margin % Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 -1.19 -1.57 7.86 12.66

Sinphar Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.64 14.67 14.20 8.44 6.35

Competitive Comparison of Sinphar Pharmaceutical Co's Net Margin %

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Net Margin % falls into.



Sinphar Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sinphar Pharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=375.17/2962.934
=12.66 %

Sinphar Pharmaceutical Co's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=47.625/749.518
=6.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinphar Pharmaceutical Co  (TPE:1734) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sinphar Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Sinphar Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinphar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines